©2022 Stanford Medicine
Effects of Low Dose Naltrexone in Fibromyalgia
Not Recruiting
Trial ID: NCT00568555
Purpose
Low Dose Naltrexone (LDN) has been reported anecdotally to reduce the symptoms of
Fibromyalgia, a Chronic Multisystem Illness. The drug may work by regulating natural
pain-reducing systems. In this study, we will administer both LDN and placebo to a small
group of individuals with Fibromyalgia and Gulf War Syndrome, both Chronic Multisymptom
Illnesses, to assess the drug's efficacy in treating the condition.
Official Title
Effects of Low Dose Naltrexone in Fibromyalgia
Eligibility
Inclusion Criteria:
Currently suffering from moderate to severe Fibromyalgia or symptoms of Gulf War Syndrome
Age 18-65. Not taking any opioid analgesic Not pregnant or planning to become pregnant.
Exclusion Criteria:
Any known allergy to naltrexone or naloxone. Actual or planned pregnancy.
Intervention(s):
drug: Placebo - sugar pill
drug: Low Dose Naltrexone
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jarred Younger